SEC Form 4 · accession 0001561743-16-000043
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denise Bevers
Officer — Chief Operating Officer
Period of report
Jan 8, 2016
Accepted (ET)
Jan 12, 2016 · 8:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.45 | Jan 8, 2016 | A | 59,031 | A | — | Jan 8, 2026 | Common Stock | 59,031 | 59,031 | D |
Explanation of responses
- F1The option will vest as to 25% after one year following the date of grant, and the remainder will vest in equal monthly installments over the following three years, provided Reporting Person remains in continuous employ of the Issuer.